DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Kalydeco, with its active ingredient ivacaftor, is a prescription medication primarily used in the treatment of a specific form of cystic fibrosis (CF) caused by certain gene mutations.